CNP
65
3
NI
72
5
DAL
85
6
BIIB
42
-2
ETN
78
2
BAX
44
-3
HRL
30
3
RHI
53
3
VIX
38
-8
AXP
73
3
ROK
46
2
CINF
38
-3
LRCX
39
-3
FIS
55
2
SWKS
43
-6
JCI
54
2
FE
44
3
DNB
62
12
DIS
56
7
CME
48
2
CNP
65
3
NI
72
5
DAL
85
6
BIIB
42
-2
ETN
78
2
BAX
44
-3
HRL
30
3
RHI
53
3
VIX
38
-8
AXP
73
3
ROK
46
2
CINF
38
-3
LRCX
39
-3
FIS
55
2
SWKS
43
-6
JCI
54
2
FE
44
3
DNB
62
12
DIS
56
7
CME
48
2
Financhill
Back

ProShares Ultra Russell2000 Vs. Kymera Therapeutics Industry Stock Comparison

Buy
70

UWM
ProShares Ultra Russell2000

Last Price:
44.79
Seasonality Move:
9.3%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
70
ProShares Ultra Russell2000 (UWM) is a Buy

Is ProShares Ultra Russell2000 a Buy, Sell or Hold?

  • The current ProShares Ultra Russell2000 [UWM] share price is $45.02. The Score for UWM is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • UWM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UWM Stock Price Chart

What is ProShares Ultra Russell2000's stock price today?

  • The ProShares Ultra Russell2000 share price today is $45.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UWM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

UWM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.63 Buy
Relative Strength Index (14 RSI): 65.6 Buy
Chaikin Money Flow: 535738 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.19 - 43.41) Buy
Bollinger Bands (100): (37.32 - 42.84) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

UWM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.66 Buy
20-day SMA: 42.52 Buy
50-day SMA: 41.08 Buy
200-day SMA: 38.64 Buy
8-day EMA: 43.14 Buy
20-day EMA: 42.39 Buy
50-day EMA: 41.49 Buy
200-day EMA: 38.74 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Ultra Russell2000 Earnings Growth & UWM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Ultra Russell2000 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):